REFERENCES
- Armitage, P. (1958), Numerical Studies in the Sequential Estimation of a Binomial Parameter, Biometrika, 45, 1–15.
- Bartroff, J., Lai, T.L., and Shih, M.-C. (2012), Sequential Experimentation in Clinical Trials: Design and Analysis (Vol. 298), New York: Springer.
- Emerson, S.S., Gillen, D.L., Kittelson, J.M., Emerson, S.C., and Levin, G.P. (2014), RCTdesign, R package. Available at http://www.rctdesign.org.
- Fay, M. (2010), Two-Sided Exact Tests and Matching Confidence Intervals for Discrete Data, R Journal, 2, 53–58.
- Freedman, L.S. (2008), On Analysis of the Controversy Over Classical One-Sided Tests, Clinical Trials, 5, 635–640.
- Hampson, L.V., Jennison, C. (2013), “Group Sequential Tests for Delayed Responses” (with discussion), Journal of the Royal Statistical Society, Series B, 75, 3–54.
- Hirjil, K. (2006), Exact Analysis of Discrete Data, New York: Chapman and Hall/CRC.
- Jennison, C., and Turnbull, B.W. (2000), Group Sequential Methods with Applications to Clinical Trials, New York: Chapman and Hall/CRC.
- Jovic, G., Whitehead, J. (2009), An Exact Method for Analysis Following a Two-Stage Phase II Cancer Trial, Statistics in Medicine, 29, 3118–3125.
- Jung, S.-H., Lee, T., Kim, K., George, S.L. (2004), Admissible Two-Stage Designs for Phase II Cancer Clinical Trials, Statistics in Medicine, 23, 561–569.
- Koyama, T., Chen, H. (2008), Proper Inference from Simon’s Two-Stage Design, Statistics in Medicine, 27, 3145–3154.
- Lan, K. K.G., DeMets, D. (1983), Discrete Sequential Boundaries for Clinical Trials, Biometrika, 70, 659–663.
- Lan, K. K.G., Wittes, J. (1988), The B-Value: A Tool for Monitoring Data, Biometrics, 44, 579–585.
- Lee, J.J., Liu, D.D. (2008), A Predictive Probability Design for Phase II Cancer Clinical Trials, Clinical Trials, 5, 93–106.
- O’Brien, P., Fleming, T. (1979), A Multiple Testing Procedure for Clinical Trials, Biometrics, 35, 549–556.
- Proschan, M.A., Lan, K. K.G., and Wittes, J. (2006), Statistical Monitoring of Clinical Trials: A Unified Approach, New York: Springer.
- Schultz, J., Nichol, F., Elfring, G., Weed, S. (1973), Multiple-Stage Procedures for Drug Screening, Biometrics, 29, 293–300.
- Seshan, V.E. (2012), clinfun: Clinical Trial Design and Data Analysis Functions, R package version 1.0.0. Available at http://cran.r-project.org/web/packages/clinfun/index.html.
- Simon, R. (1989), Optimal Two-Stage Designs for Phase II Clinical Trials, Controlled Clinical Trials, 10, 1–10.
- Thall, P.F., Simon, R. (1994), Practical Bayesian Guidelines for Phase IIB Clinical Trials, Biometrics, 50, 337–349.
- Valent, P., Gleich, G., Reiter, A., Roufosse, F., Weller, P., Hellmann, A., Metzgeroth, G., Leiferman, K., Arock, M., Sotlar, K., Butterfield, J. H., Cerny-Reiterer, S., Mayerhofer, M., Vandenberghe, P., Haferlach, T., Bochner, B. S., Gotlib, J., Horny, H.-P., Simon, H.-U., Klion, A. D. (2012), Pathogenesis and Classification of Eosinophil Disorders: A Review of Recent Developments in the Field, Expert Review of Hematology, 5, 157–176.
- Wetherill, G. (1975), Sequential Methods in Statistics (2nd ed.), New York: Chapman and Hall.